139 related articles for article (PubMed ID: 36208043)
1. Serum interleukin-33 (IL-33) in children with active systemic lupus erythematosus: A cross-sectional study.
Abd-Elazeem RI; Abdelnabi HH; Hegab DS; Mohamed WS; Ameen TE
Egypt J Immunol; 2022 Oct; 29(4):148-155. PubMed ID: 36208043
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
Front Immunol; 2018; 9():1250. PubMed ID: 29930551
[TBL] [Abstract][Full Text] [Related]
5. [Serum interleukin-2 receptor
Tian JY; Zhang X; Cheng G; Liu QH; Wang SY; He J
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1083-1087. PubMed ID: 34916686
[TBL] [Abstract][Full Text] [Related]
6. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
7. Performance of cytokine models in predicting SLE activity.
Ruchakorn N; Ngamjanyaporn P; Suangtamai T; Kafaksom T; Polpanumas C; Petpisit V; Pisitkun T; Pisitkun P
Arthritis Res Ther; 2019 Dec; 21(1):287. PubMed ID: 31842967
[TBL] [Abstract][Full Text] [Related]
8. Clinical associations of serum interleukin-17 in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Arthritis Res Ther; 2013 Aug; 15(4):R97. PubMed ID: 23968496
[TBL] [Abstract][Full Text] [Related]
9. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
10. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Raymond WD; Eilertsen GØ; Nossent J
Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
[TBL] [Abstract][Full Text] [Related]
11. Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus.
Zhang X; Liu C; Yang J; Ren H; Zhang J; Chen S; Ren J; Zhou L
Int Immunopharmacol; 2022 Oct; 111():109155. PubMed ID: 36029665
[TBL] [Abstract][Full Text] [Related]
12. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
14. Changes of Serum IL-6, IL-17, and Complements in Systemic Lupus Erythematosus Patients.
Tang Y; Tao H; Gong Y; Chen F; Li C; Yang X
J Interferon Cytokine Res; 2019 Jul; 39(7):410-415. PubMed ID: 31173544
[TBL] [Abstract][Full Text] [Related]
15. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
16. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
Front Immunol; 2021; 12():663192. PubMed ID: 34054830
[TBL] [Abstract][Full Text] [Related]
17. Increased IL-23R
Izati AF; Mohd Shukri ND; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():690908. PubMed ID: 34484186
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
19. The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis.
Abdel Galil SM; Ezzeldin N; El-Boshy ME
Cytokine; 2015 Dec; 76(2):280-287. PubMed ID: 26073684
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]